AMETEK director granted 950 restricted shares

AMETEK director Anthony James Conti received a grant of company stock as compensation.

Accepted by SEC EDGAR 03/18/2026 - 05:20 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

AMETEK director Anthony James Conti received a grant of company stock as compensation. He acquired 950 shares of AMETEK common stock on March 18, 2026, recorded at $212.77 per share, as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this award, he directly owns 30,298 common shares. This was a compensation-related grant, not an open-market purchase.

Insider Trade Summary

Grant/Award: 950 shares

Grant/Award 1 txn

Insider Conti Anthony James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	950	$212.77	$202K

Holdings After Transaction: Common Stock — 30,298 shares (Direct)

Footnotes (1)

F1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AMETEK (AME) director Anthony James Conti report in this Form 4?

Anthony James Conti reported receiving 950 shares of AMETEK common stock. The shares were granted as restricted stock under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan on March 18, 2026, reflecting a compensation-related acquisition rather than an open-market trade.

How many AMETEK (AME) shares did Anthony James Conti acquire and at what value?

He acquired 950 shares of AMETEK common stock at a recorded value of $212.77 per share. This reflects the grant-date value of the restricted stock award, issued as part of the company’s 2020 Omnibus Incentive Compensation Plan for director compensation.

Is the AMETEK (AME) Form 4 transaction an open-market purchase or a stock grant?

The transaction is a stock grant, not an open-market purchase. The Form 4 uses code “A” for a grant or award and notes the 950 shares constitute restricted stock issued under AMETEK’s 2020 Omnibus Incentive Compensation Plan for compensation purposes.

What are Anthony James Conti’s AMETEK (AME) holdings after this restricted stock grant?

After the grant, Anthony James Conti directly holds 30,298 shares of AMETEK common stock. This total includes the newly awarded 950 restricted shares under the company’s 2020 Omnibus Incentive Compensation Plan, as reported in the Form 4 filing.

What does the footnote in the AMETEK (AME) Form 4 say about the shares granted?

The footnote explains that the 950 shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This clarifies the shares are part of a structured incentive program rather than a discretionary market transaction by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conti Anthony James

(Last)

(First)

(Middle)

76 GOLF VIEW DRIVE

(Street)

IVYLAND

PENNSYLVANIA

18974

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/18/2026		A⁽¹⁾		950	A	$212.77	30,298	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Mr. Conti	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR